Durvalumab vs Propoxyphene

## Durvalumab vs Propoxyphene: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Propoxyphene**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Propoxyphene — N/A.

## Chemical Properties

**Type**: Durvalumab — Antibody; Propoxyphene — Small molecule.